Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jan 14, 2016 · 10-Q · 45 days after period end · 0001640334-16-000558
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Net Income | -$15.22K | -$2.00K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Nov 30, 2015 · filed Jan 14, 2016 · 45 d after period end
